Target intelligence / Profile preview

Gut microbiota (None commonly used)

Target
None commonly used
Molecular classification
Other (Complex microbial community), Composed primarily of bacteria (e.g., Bacteroidetes, Firmicutes), archaea, viruses/phages, fungi
01

Overview

The **gut microbiota**, also known as intestinal flora or gastrointestinal microbiome, refers to the diverse community of microorganisms inhabiting the human gastrointestinal tract. This ecosystem plays essential roles in maintaining intestinal and systemic health by regulating immune responses, supporting digestion and nutrient absorption through fermentation processes that produce beneficial metabolites like short-chain fatty acids, protecting against pathogen colonization by competitive exclusion and secretion of antimicrobial compounds/cytokines, influencing energy metabolism via interaction with hormones/neurotransmitters along the gut-brain axis—and contributing to overall host-microbe mutualism required for homeostasis. Disruption ("dysbiosis") can lead to increased risk for infections such as *Clostridioides difficile*, chronic inflammation including IBDs/autoimmunity/metabolic syndrome/neurological disorders. Therapeutic strategies focus on restoring balanced microbial communities using diet modification/prebiotic/probiotic supplementation/fecal transplantation rather than targeting any single molecular entity within this system.

Other names
Intestinal floraGut floraGastrointestinal microbiomeMicrobiome
02

Mechanism of action

For interventions targeting gut microbiota homeostasis: - Modulation/restoration of microbial diversity/composition. - Enhancement or suppression of specific metabolic pathways/metabolites production. - Strengthening mucosal barrier function or immune modulation through altered microbe-host interactions.

03

Biological functions

Maintenance of intestinal barrier integrityImmune system modulation/regulationMetabolism of dietary components (e.g., fiber fermentation)Synthesis of vitamins and bioactive metabolites (e.g., short-chain fatty acids)Defense against pathogens/colonization resistanceRegulation of energy homeostasis via gut-brain axis signaling
04

Disease associations

Inflammation (including inflammatory bowel disease)Infection susceptibility/resistanceMetabolic disorders (obesity, diabetes)Neuropsychiatric conditions via gut-brain axis
05

Safety considerations

Risk from broad-spectrum antibiotics causing dysbiosis/clostridial infectionUnpredictable effects from probiotics/fecal transplants due to individual variability in baseline floraPotential transfer/acquisition of pathogenic traits during manipulation
06

Interacting drugs

Antibiotics (alter composition broadly)

3 more in the full profile.

07

Biomarkers

Microbial diversity indices (Shannon index)Relative abundance/proportion of key taxa (Bifidobacterium, Lactobacillus, etc.)Levels of short-chain fatty acids in stool/plasma

Beyond the preview

Go deeper on Gut microbiota (None commonly used).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota (None commonly used).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call